%D8%B1%D9%88%D8%A8%D8%B1%D8%AA_%D8%BA%D8%A7%D9%84%D9%88%D0%A0%D0%BE%D0%B1%D1%8A%D1%80%D1%82_%D0%93%D0%B0%D0%BB%D0%BERobert_GalloRobert_GalloCategory:Robert_Charles_GalloRobert_GalloRobert_GalloRobert_GalloRobert_GalloRobert_GalloRobert_GalloRobert_Gallo%D8%B1%D8%A7%D8%A8%D8%B1%D8%AA_%DA%AF%D8%A7%D9%84%D9%88Robert_GalloRobert_GalloRobert_Gallo%E3%83%AD%E3%83%90%E3%83%BC%E3%83%88%E3%83%BB%E3%82%AE%E3%83%A3%E3%83%ADRobert_GalloRobert_GalloRobert_Gallo%D0%93%D0%B0%D0%BB%D0%BB%D0%BE,_%D0%A0%D0%BE%D0%B1%D0%B5%D1%80%D1%82Robert_Gallo%E0%AE%B0%E0%AE%BE%E0%AE%AA%E0%AE%B0%E0%AF%8D%E0%AE%9F%E0%AF%8D_%E0%AE%95%E0%AE%BE%E0%AE%B2%E0%AF%8D%E0%AE%B2%E0%AF%8BQ469904%E7%BD%97%E4%BC%AF%E7%89%B9%C2%B7%E6%9F%A5%E5%B0%94%E6%96%AF%C2%B7%E5%8A%A0%E6%B4%9B
about
sameAs
A reflection on HIV/AIDS research after 25 yearsRecombinant IFN-alpha (2b) increases the expression of apoptosis receptor CD95 and chemokine receptors CCR1 and CCR3 in monocytoid cellsIsolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)Engagement of CD28 modulates CXC chemokine receptor 4 surface expression in both resting and CD3-stimulated CD4+ T cellsThree distinct genes in human DNA related to the transforming genes of mammalian sarcoma retrovirusesInhibition of HIV-1 infection by the beta-chemokine MDCTumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormonePerforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1betaThe Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequenceHuman herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirusCD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virusGibbon ape leukemia virus-Hall's Island: new strain of gibbon ape leukemia virus3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitrotrans-Activation of the human T-cell leukemia virus long terminal repeat correlates with expression of the x-lor proteinSpontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free statusRole of the extracellular domain of human herpesvirus 7 glycoprotein B in virus binding to cell surface heparan sulfate proteoglycansHuman herpesvirus 6A accelerates AIDS progression in macaquesPivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replicationThe discovery of the first human retrovirus: HTLV-1 and HTLV-2Extracellular vesicles and viruses: Are they close relatives?Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 bindingOrigin of the HIV-susceptible human CD4+ cell line H9Characterization of cytopathic factors through genome-wide analysis of the Zika viral proteins in fission yeastCharacterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1Myristoylation of gag proteins of HIV-1 plays an important role in virus assemblyDetection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDSIdentification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cellsInduction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemiaIdentification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin MSequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirusEvidence for exposure to HTLV-III in Uganda before 1973HBLV (or HHV-6) in human cell linesDetection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reactionInhibition of HTLV-III/LAV replication by foscarnetIn-vitro inhibition of LAV/HTLV-III infected lymphocytes by dithiocarb and inosine pranobexProcessing of the structural proteins of human immunodeficiency virus type 1 in the presence of monensin and ceruleninLow levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replicationAntisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cellsHIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells
P50
Q21245200-5E9AAAF1-E6CD-470B-88C0-B087545A728EQ22010519-D3024B01-8407-4867-8842-E34ECD4D1BCBQ22242255-4D901878-F195-4782-904D-F53211162953Q22253854-28ED6522-12AD-477B-B32B-688F7F7C00ACQ24301108-3A25A70B-DC3F-489B-BFA2-E58EA5FE1609Q24309584-D2276A54-6B76-4302-9BE1-6140D02D7696Q24315143-2E1BE148-3270-4B25-A9A7-9B7559C3F6D5Q24555821-75627F10-8869-4055-9D88-5675648B2143Q24561727-30FC6E99-B632-463C-A524-A922794CA572Q24563317-42E8329F-FE28-4E64-9CC8-3AD08E25336DQ24563446-A35F6B24-064F-47ED-BFAE-6D8C61AC1AA2Q24594909-33D4FF3E-66D4-4D67-82DD-1FB87B582923Q24609215-88204353-E1C9-4259-A195-2174DC848A1DQ24645309-2D4D6706-2225-4D87-86B9-D4874064741EQ24672737-45AF340E-F045-4EBB-AE59-89C25D28AF0EQ24673759-F56174B9-4A1C-45BA-A392-758A250AD2A2Q24677037-7456D2BA-3E3C-4A6C-9E6B-495E4BB77A60Q24684750-193591EA-48A7-4B90-B1BC-49A6BB7BC67CQ24804470-AAF7B090-60EF-4B83-830D-7E71B6DDAF3DQ26970828-CC845266-C0E9-447B-A3B3-0B219593BBAFQ27675486-8E173DEB-AC3E-413E-A392-89691FFDBBC6Q27910572-61695628-2F36-4188-8F1F-EFA9F9B67719Q28114506-A3DF5241-8372-47AF-8898-AA9350EA702FQ28246579-B3C22974-2D59-4B5F-A51A-6A96C9A8E876Q28249070-4F32A0C3-4CA9-48CB-BAC0-D0CD42AA5D7CQ28262859-573D3247-D8BA-4A54-BE9F-F6B6D6F21D07Q28270680-08A62558-6BEF-4DDC-B471-C28D5B98A50BQ28279600-A3941C5F-AF4F-490B-A8C8-39E0F5BCB9F2Q28282977-890220D5-9540-4615-A8CE-2AA39074602CQ28284457-E83E7BE3-4848-479B-9E02-A7F278694744Q28286288-B8CBA621-967C-4627-8A1D-3147FAF7D8EFQ28286424-8D31CCD0-1965-43F4-847C-701E567AE543Q28302015-94DFBB55-9E1D-45BF-8BB5-8809CAC00866Q28306691-D226D8C3-A4C7-4711-8970-1E375BFA13F4Q28336483-B5586F77-F957-4F56-84AD-0381A7E7F874Q28336575-B5350CF3-CE2C-4261-93C2-66F9152AF9F2Q28361162-133CE784-BF83-4995-9392-C3E0E6DB1B9FQ28368051-D223FE78-7D3E-4C40-977D-CF647AA1AEB4Q28369354-CB312029-D82B-4781-AA90-BD74B049211AQ28375966-CA865B23-4F05-4784-A9B7-0C8997322DE3
P50
description
American biomedical researcher
@en
Amerikaans viroloog
@nl
US-amerikanischer Virologe
@de
amerikansk biomedisinsk forsker
@nb
amerykański wirusolog i immunolog
@pl
chercheur américain en immunologie et virologie
@fr
dokter asal Amerika Serikat
@id
investigador biomédico estadounidense
@es
medico e virologo statunitense
@it
name
Robert Charles Gallo
@de
Robert Gallo
@ast
Robert Gallo
@bs
Robert Gallo
@ca
Robert Gallo
@en
Robert Gallo
@es
Robert Gallo
@et
Robert Gallo
@eu
Robert Gallo
@fi
Robert Gallo
@fr
type
label
Robert Charles Gallo
@de
Robert Gallo
@ast
Robert Gallo
@bs
Robert Gallo
@ca
Robert Gallo
@en
Robert Gallo
@es
Robert Gallo
@et
Robert Gallo
@eu
Robert Gallo
@fi
Robert Gallo
@fr
altLabel
R C Gallo
@en
Robert C Gallo
@es
Robert C. Gallo
@de
Robert C. Gallo
@es
Robert C. Gallo
@fr
Robert Charles Gallo
@en
Robert Charles Gallo
@es
Robert Charles Gallo
@et
Robert Charles Gallo
@fr
Robert Gallo
@de
prefLabel
Robert Charles Gallo
@de
Robert Gallo
@ast
Robert Gallo
@bs
Robert Gallo
@ca
Robert Gallo
@en
Robert Gallo
@es
Robert Gallo
@et
Robert Gallo
@eu
Robert Gallo
@fi
Robert Gallo
@fr